# Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.

> **NCT06158230** · PHASE2 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 140 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Pizotifen
- **DRUG:** Amitriptyline-propranolol

## Key facts

- **NCT ID:** NCT06158230
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-19
- **Primary completion:** 2023-11-25
- **Final completion:** 2024-01-15
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06158230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06158230, "Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06158230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*